Pear scores Breakthrough Device Designation for digital therapeutic aimed at alcohol use disorder
The news comes just as Pear is finalizing its SPAC merger.
Stay updated with breaking news from Breakthrough Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The news comes just as Pear is finalizing its SPAC merger.
- It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years LONDON, Nov. 20, 2021 /PRNewswire/ -- Datar Cancer Genetics, a leading cancer research company focussed on early detection of cancers today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation'...
/PRNewswire/ -- Renovia Inc. ("Renovia"), a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that the...
/PRNewswire/ - The Breakthrough Device Designation is an FDA designation granted to devices that provide more effective treatment or diagnosis of...
/PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostic, and biologics advisory firm and clinical research organization (CRO) integrating U.S....